Gastric vs transpyloric feeding for BPD
Part of Digestive system, Genetic & congenital, Lungs & breathing clinical trials.
This study compares two ways of feeding premature babies with lung disease (BPD) who still need breathing support: feeding through a tube into the stomach (gastric) versus past the stomach into the small intestine (transpyloric). The goal is to see which feeding method helps these babies grow better and avoid problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby was born before 32 weeks of pregnancy.
- Your baby is now between 36 and 65 weeks old (counting from conception).
- Your baby has BPD (a chronic lung condition) and still needs breathing support at the time of the study.
- Your baby is receiving all their nutrition through a tube into the stomach.
- Your baby has not had a feeding tube past the stomach in the last week.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two ways of feeding infants with severe bronchopulmonary dysplasia (a chronic lung condition in premature babies) to see which helps with feeding problems such as reflux or aspiration. Infants will try both methods at different times to find out which works best.
This study tests whether placing a feeding tube past the stomach (postpyloric) can help very premature babies with ongoing lung problems breathe better. Infants born before 32 weeks who still need breathing support may join.
This study looks at babies born very early who have severe lung disease (grade 3 BPD) and still need a breathing machine. Researchers will use tests to understand their lung problems better, which may help guide their care.
This trial tests whether feeding extremely premature babies (born at 28 weeks or earlier) a higher-energy breast milk diet in the first two weeks of life can reduce the risk of bronchopulmonary dysplasia (BPD), a serious lung condition. It aims to find a safe and effective way to support lung development in these tiny infants.
This trial tests a standardized, team-agreed discharge plan to help preterm babies with lung disease (often called BPD) leave the hospital safely. It may help by making the discharge process more consistent, especially for babies going home on breathing support like oxygen.
This Phase 1 trial tests whether giving stem cells into a breathing tube is safe and may help prevent bronchopulmonary dysplasia (BPD), a serious lung condition in very premature infants. It focuses on babies soon after birth who already need breathing support and are at risk.
Hear when a new Bronchopulmonary Dysplasia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.